PI3Kγ inhibitor 4
Modify Date: 2024-01-16 07:44:51
PI3Kγ inhibitor 4 structure
|
Common Name | PI3Kγ inhibitor 4 | ||
|---|---|---|---|---|
| CAS Number | 1821038-80-5 | Molecular Weight | 416.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H24N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PI3Kγ inhibitor 4PI3Kγ inhibitor 4 is a potent, selective and orally active inhibitor of PI3Kγ, with an IC50 of 40 nM. PI3Kγ inhibitor 4 shows ∼7, 43, and 18-fold selectivity for PI3Kγ over the α, β, and δ isoforms, respectively. PI3Kγ inhibitor 4 can be used for the research of airway inflammation[1]. |
| Name | PI3Kγ inhibitor 4 |
|---|
| Description | PI3Kγ inhibitor 4 is a potent, selective and orally active inhibitor of PI3Kγ, with an IC50 of 40 nM. PI3Kγ inhibitor 4 shows ∼7, 43, and 18-fold selectivity for PI3Kγ over the α, β, and δ isoforms, respectively. PI3Kγ inhibitor 4 can be used for the research of airway inflammation[1]. |
|---|---|
| Related Catalog | |
| Target |
PI3Kγ:40 nM (IC50) PI3Kα:300 nM (IC50) |
| In Vitro | PI3Kγ inhibitor 4 inhibits PI3Kγ and PI3Kα in U937 cells, with IC50s of 120 nM and 6250 nM, respectively[1]. |
| In Vivo | PI3Kγ inhibitor 4 (10-20 mg/kg; a single p.o.) dose dependently inhibits the amplitude of the enhanced pause (ΔPenh) response to ovalbumin in a model of airway inflammation[1]. PI3Kγ inhibitor 4 (a single p.o.) exhibits high oral bioavailability (72, 94 and 122%) and Cmax (1.53, 12.2 and 25.2 μM) following oral administration (10, 100 and 300 mg/kg) in rats[1]. |
| References |
| Molecular Formula | C20H24N4O4S |
|---|---|
| Molecular Weight | 416.49 |